Biomarkers in Ulcerative Colitis
Key Points
Key Points
- There is an important need for understanding how noninvasive biomarkers may serve as accurate and reliable surrogates for endoscopic assessment of inflammation.
- Commonly available biomarkers are well-established as surrogate tests for endoscopic assessment of disease and in longitudinal monitoring of patients with an established diagnosis of ulcerative colitis (UC).
- This guideline focuses on the following biomarkers: serum C-reactive protein (CRP), fecal calprotectin, and fecal lactoferrin.
Diagnosis
...gnosis...
...mary of Recommendatio...
...nts With Ulcerative Colitis in Symptomatic Re...
...tients with UC in symptomatic remission,...
...cal calprotectin...
...ormal fecal lactoferrin (C, L)62...
...VL)Implementation consideration:...
...with UC in symptomatic remission but el...
...ymptomatically Active Ulcerative Coli...
...ith symptomatically active UC, the AGA suggests a...
...alprotectin >150 μg/g (C,...
...levated fecal lactoferrin (C,...
...vated CRP (C, M)620...
...UC with mild symptoms, with elevated stoo...
...atients with UC with mild symptoms, with no...
...et Strategies for Ulcerative Colitis...
...s with UC, the AGA makes no recommendati...
...Considerations When Using Biomarkers for M...
Treatment
Treatm...
...s of Diagnostic Test Results on Patient-...